{"id":4668,"date":"2016-10-12T08:38:16","date_gmt":"2016-10-12T12:38:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4668"},"modified":"2016-10-12T08:38:16","modified_gmt":"2016-10-12T12:38:16","slug":"senator-demands-federal-agencies-limit-use-of-prescription-fentanyl","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4668","title":{"rendered":"Senator demands federal agencies limit use of prescription fentanyl"},"content":{"rendered":"<p>(By David Armstrong for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">A<\/span> US senator is urging federal agencies to limit the use of a prescription version of the powerful painkiller fentanyl, going so far as to say the government may be helping to fuel the <a href=\"https:\/\/www.statnews.com\/feature\/opioid-crisis\/dope-sick\/\" target=\"_blank\">ongoing opioid epidemic<\/a><sup class=\"footnote\">1<\/sup> by failing to more aggressively police its use. <a href=\"https:\/\/www.statnews.com\/2016\/10\/11\/fentanyl-subsys-markey-letters\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;.<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By David Armstrong for STAT) A US senator is urging federal agencies to limit the use of a prescription version<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,6,15],"tags":[],"class_list":["post-4668","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4668"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4668\/revisions"}],"predecessor-version":[{"id":4669,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4668\/revisions\/4669"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}